Temat: "Lymphoma, Non-Hodgkin" - OpacWWW

Skocz do pozycji: 61.

Tytuł:: Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphoma.
Autorzy:: Cheng CL; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Yeh PT; Department of Ophthalmology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Fang WQ; Division of New Drug, Center for Drug Evaluation, Taipei, Taiwan.
Ma WL; Department of Oncology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Hou HA; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Tsai CH; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Lin CP; Department of Ophthalmology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Tien HF; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (7), pp. 8102-8111. Date of Electronic Publication: 2023 Jan 05.
Typ publikacji:: Journal Article
MeSH Terms:: Retinal Neoplasms*/drug therapy
Lymphoma, Non-Hodgkin*/drug therapy
Eye Neoplasms*
Central Nervous System Neoplasms*
Humans ; Methotrexate ; Retrospective Studies ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Vitreous Body/pathology ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 62.

Tytuł:: CAR T-Cell therapy for the management of mantle cell lymphoma.
Autorzy:: Huang Z; Department of Hematology, Ganzhou Key Laboratory of Hematology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Chavda VP; Department of Pharmaceutics and Pharmaceutical Technology, L M College of Pharmacy, Ahmedabad, , 380009, Gujarat, India. .
Bezbaruah R; Department of Pharmaceutical Sciences, Faculty of Science and Engineering, Dibrugarh University, Dibrugarh, India.
Dhamne H; Process Development, Gene Therapy Vector Facility, Research Management and Innvotations Directorate, King's College London, London, WC2R 2LS, UK.
Yang DH; New York College of Traditional Chinese Medicine, Mineola, NY, 11501, USA.
Zhao HB; Department of Oncology, the First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China. .; Pokaż więcej
Źródło:: Molecular cancer [Mol Cancer] 2023 Mar 31; Vol. 22 (1), pp. 67. Date of Electronic Publication: 2023 Mar 31.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Lymphoma, Mantle-Cell*/therapy
Lymphoma, Mantle-Cell*/genetics
Lymphoma, Non-Hodgkin*
Receptors, Chimeric Antigen*/genetics
Adult ; Humans ; Male ; Immunotherapy, Adoptive/adverse effects ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 63.

Tytuł:: Primary breast B-cell non-Hodgkin’s lymphoma of the breast. Case Report and review of the literature
Autorzy:: Santiago-Sanabria L; Hospital Ángeles Lomas, Huixquilican, Estado de México (México).. .
Garza-Arrieta J; Hospital Ángeles Lomas, Huixquilican, Estado de México (México).. .
Porras-Ibarra GD; Hospital Ángeles Lomas, Huixquilican, Estado de México (México).. .
Malfavón-Farias M; Hospital ABC, Santa Fe, Cuajimalpa, Ciudad de México (México).. .; Pokaż więcej
Transliterated Title:: Linfoma no Hodgkin de células B primario de mama. Reporte de caso y revisión de la literatura
Źródło:: Revista colombiana de obstetricia y ginecologia [Rev Colomb Obstet Ginecol] 2023 Mar 30; Vol. 74 (1), pp. 53-67. Date of Electronic Publication: 2023 Mar 30.
Typ publikacji:: Journal Article
MeSH Terms:: Lymphoma, Non-Hodgkin*
Antineoplastic Combined Chemotherapy Protocols*
Humans ; Mexico ; Rituximab/therapeutic use ; Female ; Aged, 80 and over ; Cyclophosphamide/therapeutic use ; Doxorubicin ; Vincristine ; Prednisone ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 64.

Tytuł:: Identification of two unannotated miRNAs in classic Hodgkin lymphoma cell lines.
Autorzy:: Ustaszewski A; Institute of Human Genetics, Polish Academy of Sciences Poznan, Poznan, Poland.
Paczkowska J; Institute of Human Genetics, Polish Academy of Sciences Poznan, Poznan, Poland.
Janiszewska J; Institute of Human Genetics, Polish Academy of Sciences Poznan, Poznan, Poland.
Bernhart SH; Interdisciplinary Center for Bioinformatics, Transcriptome Bioinformatics, University of Leipzig, Leipzig, Germany.
Bein J; Dr. Senckenberg Institute of Pathology, Goethe University Frankfurt, Frankfurt am Main, Germany.
Russiñol N; Institut d'Investigacions Biomèdiques August Pi I Sunyer, IDIBAPS, Barcelona, Spain.
Hansmann ML; Frankfurt Institute of Advanced Studies, Frankfurt am Main, Germany.; Institute of General Pharmacology and Toxicology, Goethe University Frankfurt, Frankfurt am Main, Germany.
Chapaprieta V; Institut d'Investigacions Biomèdiques August Pi I Sunyer, IDIBAPS, Barcelona, Spain.
Martín-Subero JI; Institut d'Investigacions Biomèdiques August Pi I Sunyer, IDIBAPS, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Pamplona, Spain.; Facultat de Medicina, Hospital Clínic de Barcelona and Departament de Fonaments Clínics, Universitat de Barcelona, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats, ICREA, Barcelona, Spain.
Siebert R; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
Hartmann S; Dr. Senckenberg Institute of Pathology, Goethe University Frankfurt, Frankfurt am Main, Germany.
Giefing M; Institute of Human Genetics, Polish Academy of Sciences Poznan, Poznan, Poland.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Mar 24; Vol. 18 (3), pp. e0283186. Date of Electronic Publication: 2023 Mar 24 (Print Publication: 2023).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: MicroRNAs*/genetics
MicroRNAs*/metabolism
Hodgkin Disease*/pathology
Lymphoma, B-Cell*/genetics
Lymphoma, Non-Hodgkin*/genetics
Humans ; Cell Line ; Germinal Center/pathology ; Gene Expression Regulation, Neoplastic ; Transcription Factor TFIIH/genetics ; Transcription Factor TFIIH/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 65.

Tytuł:: Clinical features predictive of vision loss in patients with vitreoretinal lymphoma: a single tertiary center experience.
Autorzy:: Kim M; Department of Ophthalmology and Visual Science, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-Gu, Seoul, 06591, South Korea.; Seoul St. Mary's Hospital, Seoul, South Korea.
Suh H; Department of Ophthalmology and Visual Science, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-Gu, Seoul, 06591, South Korea.; Seoul St. Mary's Hospital, Seoul, South Korea.
Park YG; Department of Ophthalmology and Visual Science, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-Gu, Seoul, 06591, South Korea.; Seoul St. Mary's Hospital, Seoul, South Korea.
Park YH; Department of Ophthalmology and Visual Science, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-Gu, Seoul, 06591, South Korea. .; Seoul St. Mary's Hospital, Seoul, South Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Mar 18; Vol. 13 (1), pp. 4478. Date of Electronic Publication: 2023 Mar 18.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Retinal Neoplasms*/complications
Retinal Neoplasms*/drug therapy
Eye Neoplasms*
Lymphoma, Non-Hodgkin*
Humans ; Middle Aged ; Aged ; Longitudinal Studies ; Retrospective Studies ; Vitreous Body ; Vision Disorders ; Tomography, Optical Coherence ; Treatment Outcome ; Intravitreal Injections ; Follow-Up Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 66.

Tytuł:: COVID-19 and non-Hodgkin's lymphoma: A common susceptibility pattern?
Autorzy:: Sara M; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Minelli C; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Broccia G; Private Consultant, Former director of the Department of Haematology and Bone Marrow Transplants, Hospital A. Businco, Cagliari, Italy.
Vineis P; Faculty of Medicine, School of Public Health, Imperial College, London, United Kingdom.
Cocco P; Centre for Occupational and Environmental Health, Division of Population Health, University of Manchester, Manchester, United Kingdom.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Mar 16; Vol. 18 (3), pp. e0277588. Date of Electronic Publication: 2023 Mar 16 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*/epidemiology
Lymphoma, Non-Hodgkin*/epidemiology
Humans ; Aged ; Incidence ; Italy/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 67.

Tytuł:: Role and mechanism of PIM family in the immune microenvironment of diffuse large B cell lymphoma.
Autorzy:: Wang C; Department of Oncology, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, 441000, China.
Chen Q; Department of Oncology, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, 441000, China.
Luo H; Department of Oncology, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, 441000, China. .
Chen R; Department of Oncology, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, 441000, China. .; Pokaż więcej
Źródło:: World journal of surgical oncology [World J Surg Oncol] 2023 Mar 04; Vol. 21 (1), pp. 76. Date of Electronic Publication: 2023 Mar 04.
Typ publikacji:: Journal Article
MeSH Terms:: Lymphoma, Large B-Cell, Diffuse*
Lymphoma, Non-Hodgkin*
Humans ; Databases, Factual ; Mutation ; Staining and Labeling ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 68.

Tytuł:: 2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma.
Autorzy:: Li P; Department of Hematology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.
Liu Y; Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing 100853, China.
Liang Y; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, China.
Bo J; Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China.
Gao S; Department of Hematology, The First Hospital of Jilin University, Changchun 130012, China.
Hu Y; Center for Bone Marrow Transplantation, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310058, China.
Hu Y; Institute of Hematology, Union Hospital of Tongji Medical College; Huazhong University of Science and Technology, Wuhan 430022, China.
Huang H; Center for Bone Marrow Transplantation, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310058, China.
Huang X; Peking University People's Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Jing H; Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing 100191, China.
Ke X; Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing 100191, China.
Li J; Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China.
Li Y; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Liu Q; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Lu P; Lu Daopei Institute of Hematology, Beijing 101102, China.
Mei H; Institute of Hematology, Union Hospital of Tongji Medical College; Huazhong University of Science and Technology, Wuhan 430022, China.
Niu T; Department of Hematology, West China Hospital, Sichuan University, Chengdu 610041, China.
Song Y; The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
Song Y; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing 100142, China.
Su L; Department of Hematology, Shanxi Cancer Hospital, Taiyuan 030013, China.
Tu S; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Wang J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Division of Pediatric Blood Disease Center, Institute of Hematology & Blood Disease Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Wu D; Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou 215006, China.
Wang Z; Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Xu K; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, China.
Ying Z; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing 100142, China.
Yang Q; Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing 100853, China.
Zhang Y; Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing 100853, China.
Shi F; Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing 100853, China.
Zhang B; Institute of Blood and Marrow Transplantation, The Fifth Medical Center, Chinese PLA General Hospital, Beijing 100039, China.
Zhang H; Department of Lymphoma, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
Zhang X; Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing 400037, China.
Zhao M; Department of Hematology, Tianjin First Central Hospital, Tianjin 300192, China.
Zhao W; Department of Hematology, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Zhao X; Peking University People's Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Huang L; Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Zhu J; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing 100142, China.
Qian W; Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, China.
Han W; Department of Bio-therapeutic, Chinese PLA General Hospital, Beijing 100853, China.
Liang A; Department of Hematology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China.; Pokaż więcej
Źródło:: Cancer biology & medicine [Cancer Biol Med] 2023 Mar 02; Vol. 20 (2).
Typ publikacji:: Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
MeSH Terms:: Immunotherapy, Adoptive*/adverse effects
Lymphoma, Non-Hodgkin*/therapy
Receptors, Chimeric Antigen*
Humans ; Adaptor Proteins, Signal Transducing ; Antigens, CD19 ; Cell- and Tissue-Based Therapy/adverse effects ; Consensus

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 69.

Tytuł:: Should WE use flow cytometry to assess bone marrow involvement by lymphoma?
Autorzy:: Jurado R; Hematology Laboratory, Unitat de citometria ICO-Badalona (CITICOB), Hospital Germans Trias i Pujol, IJC, LUMN, Universitat Autònoma de Barcelona, Badalona, Spain.
Aren M; Hematology Laboratory, Unitat de citometria ICO-Badalona (CITICOB), Hospital Germans Trias i Pujol, IJC, LUMN, Universitat Autònoma de Barcelona, Badalona, Spain.
Sorigue M; Hematology Laboratory, Unitat de citometria ICO-Badalona (CITICOB), Hospital Germans Trias i Pujol, IJC, LUMN, Universitat Autònoma de Barcelona, Badalona, Spain.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2023 Mar; Vol. 64 (3), pp. 753-755. Date of Electronic Publication: 2023 Mar 08.
Typ publikacji:: Journal Article
MeSH Terms:: Lymphoma*/diagnosis
Lymphoma*/pathology
Lymphoma, Non-Hodgkin*/pathology
Humans ; Bone Marrow/pathology ; Flow Cytometry ; Immunophenotyping

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 70.

Tytuł:: Design of Novel Phosphatidylinositol 3-Kinase Inhibitors for Non-Hodgkin's Lymphoma: Molecular Docking, Molecular Dynamics, and Density Functional Theory Studies on Gold Nanoparticles.
Autorzy:: Ali AM; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Gezira, Gezira 12217, Sudan.
Makki AA; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Gezira, Gezira 12217, Sudan.
Ibraheem W; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Gezira, Gezira 12217, Sudan.
Abdelrahman M; Department of Pharmaceutics, Faculty of Pharmacy, University of Gezira, Gezira 12217, Sudan.
Osman W; Department of Pharmacognosy, Faculty of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-kharj 11942, Saudi Arabia.; Department of Pharmacognosy, Faculty of Pharmacy, University of Khartoum, Al-Qasr Ave, Khartoum 11111, Sudan.
Sherif AE; Department of Pharmacognosy, Faculty of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-kharj 11942, Saudi Arabia.; Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
Ashour A; Department of Pharmacognosy, Faculty of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-kharj 11942, Saudi Arabia.; Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
Ibrahim SRM; Preparatory Year Program, Department of Chemistry, Batterjee Medical College, Jeddah 21442, Saudi Arabia.; Department of Pharmacognosy, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt.
Ghazawi KF; Clinical Pharmacy Department, College of Pharmacy, Umm Al-Qura University, Makkah 24382, Saudi Arabia.
Samman WA; Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Al-Madinah Al-Munawwarah 30078, Saudi Arabia.
Alzain AA; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Gezira, Gezira 12217, Sudan.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2023 Mar 01; Vol. 28 (5). Date of Electronic Publication: 2023 Mar 01.
Typ publikacji:: Journal Article
MeSH Terms:: Metal Nanoparticles*
Lymphoma, Non-Hodgkin*/drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy
Humans ; Phosphoinositide-3 Kinase Inhibitors ; Phosphatidylinositol 3-Kinases ; Molecular Dynamics Simulation ; Gold/therapeutic use ; Molecular Docking Simulation ; Proto-Oncogene Proteins c-akt ; Ligands ; Density Functional Theory

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 71.

Tytuł:: A phase II study to evaluate the efficacy of low-dose rasburicase (1.5mg) in adolescent and adult acute leukemia and high-grade lymphomas with tumor lysis syndrome.
Autorzy:: Majumdar S; Medical Oncology, MS Ramaiah Medical College, Rajiv Gandhi University of Health Sciences, Bangalore, India.
Sharma N; Medical Oncology, Tata Memorial Centre, Homi Bhabha National University, Mumbai, India.
Sengar M; Medical Oncology, MS Ramaiah Medical College, Rajiv Gandhi University of Health Sciences, Bangalore, India.
Thorat J; Medical Oncology, MS Ramaiah Medical College, Rajiv Gandhi University of Health Sciences, Bangalore, India.
Nayak L; Medical Oncology, MS Ramaiah Medical College, Rajiv Gandhi University of Health Sciences, Bangalore, India.
Bonda A; Medical Oncology, Homi Bhabha Cancer Hospital & Research Centre, Tata Memorial Centre, Mumbai, India.
Bagal B; Medical Oncology, MS Ramaiah Medical College, Rajiv Gandhi University of Health Sciences, Bangalore, India.
Rajendra A; Department of Medical Oncology, Cancer Institute WIA, Adyar, Chennai, India.
Sethi A; Department of Electrical Engineering, Indian Institute of Bombay, Powai, India.
Jain H; Medical Oncology, MS Ramaiah Medical College, Rajiv Gandhi University of Health Sciences, Bangalore, India.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2023 Mar; Vol. 64 (3), pp. 628-638. Date of Electronic Publication: 2023 Mar 08.
Typ publikacji:: Clinical Trial, Phase II; Journal Article
MeSH Terms:: Tumor Lysis Syndrome*/diagnosis
Tumor Lysis Syndrome*/drug therapy
Tumor Lysis Syndrome*/etiology
Lymphoma, Non-Hodgkin*
Leukemia, Myeloid, Acute*
Adult ; Humans ; Adolescent ; Uric Acid ; Urate Oxidase/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 72.

Tytuł:: Osmotic demyelination syndrome in patients with non-Hodgkin lymphoma: a case report and literature review.
Autorzy:: García-Grimshaw M; Department of Neurology and Psychiatry, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, México.
Jiménez-Ruiz A; Department of Neurology and Psychiatry, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, México.
Ruiz-Sandoval JL; Department of Neurology, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, México.
Cantú-Brito C; Department of Neurology and Psychiatry, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, México.
Chiquete E; Department of Neurology and Psychiatry, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, México.; Pokaż więcej
Źródło:: The International journal of neuroscience [Int J Neurosci] 2023 Mar; Vol. 133 (3), pp. 233-237. Date of Electronic Publication: 2021 Sep 24.
Typ publikacji:: Review; Case Reports; Journal Article
MeSH Terms:: Demyelinating Diseases*/complications
Hyponatremia*/complications
Alcoholism*/complications
Lymphoma, Non-Hodgkin*/complications
Female ; Humans ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 73.

Tytuł:: Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high-grade multicentric lymphoma.
Autorzy:: Veluvolu S; William R Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.
Willcox JL; William R Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.
Skorupski KA; William R Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.
Al-Nadaf S; William R Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.
Rebhun R; William R Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.
Wittenburg L; Department of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.; Pokaż więcej
Źródło:: Veterinary and comparative oncology [Vet Comp Oncol] 2023 Mar; Vol. 21 (1), pp. 20-27. Date of Electronic Publication: 2022 Sep 14.
Typ publikacji:: Journal Article
MeSH Terms:: Dog Diseases*/drug therapy
Neoplasms*/veterinary
Lymphoma, Non-Hodgkin*/veterinary
Humans ; Dogs ; Animals ; Cyclophosphamide ; Area Under Curve

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 74.

Tytuł:: The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter study.
Autorzy:: Shargian L; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Amit O; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Institute of Hematology, Sourasky Medical Center, Tel-Aviv, Israel.
Bernstine H; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Department of Nuclear Medicine, Rabin Medical Center, Petah-Tikva, Israel.
Gurion R; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Gafter-Gvili A; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Rozovski U; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Pasvolsky O; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Perets G; Department of Hematology and Bone Marrow Transplantation, Soroka Medical center and Faculty of Medicine, Beer Sheva, Israel.
Horowitz NA; Department of Hematology and BMT, Rambam Health Care Campus, Haifa, Israel.; The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Halloun J; Hillel Yaffe Medical Center, Hadera, Israel.
Perry C; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Institute of Hematology, Sourasky Medical Center, Tel-Aviv, Israel.
Avivi I; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Institute of Hematology, Sourasky Medical Center, Tel-Aviv, Israel.
Raanani P; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Yeshurun M; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Ram R; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Institute of Hematology, Sourasky Medical Center, Tel-Aviv, Israel.; Pokaż więcej
Źródło:: European journal of haematology [Eur J Haematol] 2023 Feb; Vol. 110 (2), pp. 149-156. Date of Electronic Publication: 2022 Oct 25.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lymphoma, Non-Hodgkin*/drug therapy
Neoplasm Recurrence, Local*/drug therapy
Adult ; Humans ; Retrospective Studies ; Transplantation, Autologous

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 75.

Tytuł:: Seasonal effects on cancer incidence and prognosis.
Autorzy:: Wikén I; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Andersson TM; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Radkiewicz C; Upper Gastrointestinal Surgery/Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Pokaż więcej
Źródło:: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Feb; Vol. 62 (2), pp. 103-109. Date of Electronic Publication: 2023 Feb 15.
Typ publikacji:: Journal Article
MeSH Terms:: Skin Neoplasms*
Leukemia*
Lymphoma, Non-Hodgkin*/epidemiology
Lung Neoplasms*
Male ; Humans ; Incidence ; Seasons ; Cohort Studies ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 76.

Tytuł:: Subcutaneous rituximab in patients with diffuse large B cell lymphoma and follicular lymphoma: Final results of the non-interventional study MabSCale.
Autorzy:: Dürig J; Department of Hematology, University Medicine Essen, Essen, Germany.
Uhlig J; Oncological Practice, Naunhof, Germany.
Gerhardt A; Medical Care Centre for Blood and Cancer Diseases, Potsdam, Germany.
Ritter M; Department of Hematology and Oncology, Hospital Sindelfingen-Böblingen, Germany.
Hapke G; Marienkrankenhaus Hamburg, Hamburg, Germany.
Heßling J; Onkologie am Segelfliegerdamm, Berlin, Germany.
Staib P; St.-Antonius Hospital, Eschweiler, Germany.
Wolff F; Roche Pharma AG, Biometrics & Epidemiology, Grenzach-Wyhlen, Germany.
Krumm K; Roche Pharma AG, Department of Hematology, Grenzach-Wyhlen, Germany.
von Weikersthal LF; St. Marien Health Centre, Amberg, Germany.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (3), pp. 2739-2751. Date of Electronic Publication: 2022 Aug 26.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Lymphoma, Follicular*/drug therapy
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lymphoma, Non-Hodgkin*/drug therapy
Adult ; Humans ; Rituximab/therapeutic use ; Administration, Intravenous ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 77.

Tytuł:: Health-related quality of life and chronic fatigue in long-term survivors of indolent lymphoma - a comparison with normative data.
Autorzy:: Kiserud CE; National Advisory Unit for Late Effects after Cancer, Oslo University Hospital, Oslo, Norway.
Lockmer S; Department of Medicine, Center for Hematology and Regenerative Medicine, Stockholm, Sweden.; Karolinska Institutet, and Hematology Center, Karolinska University Hospital, Stockholm, Sweden.
Baerug I; National Advisory Unit for Late Effects after Cancer, Oslo University Hospital, Oslo, Norway.
Dahl AA; National Advisory Unit for Late Effects after Cancer, Oslo University Hospital, Oslo, Norway.
Kimby E; Department of Medicine,Unit of Hematology, Karolinska Institutet, Stockholm, Sweden.
Østenstad B; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2023 Feb; Vol. 64 (2), pp. 349-355. Date of Electronic Publication: 2022 Nov 07.
Typ publikacji:: Journal Article
MeSH Terms:: Fatigue Syndrome, Chronic*
Lymphoma, Non-Hodgkin*
Lymphoma*/complications
Lymphoma*/diagnosis
Lymphoma*/epidemiology
Humans ; Quality of Life ; Follow-Up Studies ; Survivors ; Surveys and Questionnaires

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 78.

Tytuł:: Capturing the lived experiences of women with lymphoma in pregnancy: a qualitative study.
Autorzy:: Mills GS; Department of Hematology, Northern Beaches Hospital, Frenchs Forest, Australia.; Northern Beaches Clinical School, Macquarie University, Sydney, Australia.; Department of Hematology and Bone Marrow Transplant, St. Vincent's Hospital, Darlinghurst, Australia.
Di Ciaccio PR; Department of Hematology, Sydney Adventist Hospital, Sydney, Australia.; School of Medicine, University of New South Wales, Sydney, Australia.
Tang C; Department of Hematology, Gosford Hospital, Gosford, Australia.; Department of Haematology, Wellington Hospital, Wellington, New Zealand.
Chadwick V; Department of Hematology and Bone Marrow Transplant, St. Vincent's Hospital, Darlinghurst, Australia.
Mason KD; Department of Clinical Hematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Clinical Pathology, The University of Melbourne, Parkville, Australia.
Campbell BA; Department of Clinical Pathology, The University of Melbourne, Parkville, Australia.; Department of Radiation Oncology, Melbourne, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
Shipton MJ; Department of Clinical Hematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, Australia.
Shanavas M; Department of Haematology, Mater Hospital, Brisbane, Australia.; Department of Medicine, University of Queensland, Brisbane, Australia.
Morris KL; Department of Haematology, Royal Brisbane and Women's Hospital, Brisbane, Australia.
Greenwood M; Department of Haematology, Royal North Shore Hospital, Sydney, Australia.; School of Medicine, University of Sydney, Sydney, Australia.
Langfield J; Department of Haematology, Royal North Shore Hospital, Sydney, Australia.; School of Medicine, University of Sydney, Sydney, Australia.
Kidson-Gerber G; School of Medicine, University of New South Wales, Sydney, Australia.; Department of Haematology, Prince of Wales Hospital and The Royal Hospital for Women, Randwick, Australia.
Eslick R; Department of Haematology, The Canberra Hospital, Canberra, Australia.
Badoux X; Department of Haematology, St. George Hospital, Sydney, Australia.
Yannakou CK; Department of Molecular Oncology and Cancer Immunology, Epworth HealthCare, Melbourne, Australia.
Gangatharan SA; Fiona Stanley Hospital, Murdoch, Australia.; School of Medicine, University of Western Australia, Nedlands, Australia.
Bilmon I; Department of Hematology and Bone Marrow Transplant, Westmead Hospital, Westmead, Australia.
Hamad N; Department of Hematology and Bone Marrow Transplant, St. Vincent's Hospital, Darlinghurst, Australia.; School of Medicine, University of New South Wales, Sydney, Australia.; School of Medicine, University of Notre Dame, Sydney, Australia.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2023 Feb; Vol. 64 (2), pp. 319-328. Date of Electronic Publication: 2022 Nov 24.
Typ publikacji:: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Neoplasms*
Lymphoma, Non-Hodgkin*
Humans ; Pregnancy ; Child ; Female ; Adolescent ; Adult ; Infant ; Delayed Diagnosis ; Fear ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 79.

Tytuł:: Central nervous system involvement by mantle cell lymphoma.
Autorzy:: McLaughlin N; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Wang Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Witzig T; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Villasboas J; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Habermann T; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Inwards D; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Bennani N; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Thanarajasingam G; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Nowakowski G; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Porrata L; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Thompson C; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Micallef I; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Johnston P; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Ansell S; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Paludo J; Division of Hematology, Mayo Clinic, Rochester, MN, USA.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2023 Feb; Vol. 64 (2), pp. 371-377. Date of Electronic Publication: 2022 Nov 23.
Typ publikacji:: Journal Article
MeSH Terms:: Lymphoma, Mantle-Cell*/diagnosis
Lymphoma, Mantle-Cell*/therapy
Lymphoma, Mantle-Cell*/pathology
Lymphoma, Non-Hodgkin*/pathology
Central Nervous System Neoplasms*/diagnosis
Central Nervous System Neoplasms*/etiology
Central Nervous System Neoplasms*/therapy
Adult ; Humans ; Central Nervous System/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 80.

Tytuł:: Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality.
Autorzy:: Parsons MW; Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Rock C; Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Chipman JJ; Cancer Biostatistics, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Division of Biostatistics, Department of Population Health Sciences, University of Utah, Salt Lake City, Utah, USA.
Shah HR; Division of Hematology/Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Hu B; Division of Hematology/Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Stephens DM; Division of Hematology/Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Tao R; Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Tward JD; Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Gaffney DK; Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (3), pp. 2624-2636. Date of Electronic Publication: 2022 Aug 17.
Typ publikacji:: Journal Article
MeSH Terms:: Lymphoma, Non-Hodgkin*/epidemiology
Neoplasms, Second Primary*/epidemiology
Humans ; Follow-Up Studies ; Survivors ; Risk ; Incidence ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Lymphoma, Non-Hodgkin"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język